UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026151
Receipt number R000030047
Scientific Title Effect of branched chain amino acid with exercise on elderly patients with total hip arthroplasty and THA revision: Confirmatory study
Date of disclosure of the study information 2017/02/15
Last modified on 2020/07/13 09:21:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of branched chain amino acid with exercise on elderly patients with total hip arthroplasty and THA revision: Confirmatory study

Acronym

Effect of branched chain amino acid with exercise on patients with total hip arthroplasty and THA revision

Scientific Title

Effect of branched chain amino acid with exercise on elderly patients with total hip arthroplasty and THA revision: Confirmatory study

Scientific Title:Acronym

Effect of branched chain amino acid with exercise on patients with total hip arthroplasty and THA revision

Region

Japan


Condition

Condition

Total hip arthroplasty
Revision for Total hip arthroplasty

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Using randomized control trial, This study examined the efficacy of muscle strength exercise combined with branched chain amino acid supplementation to physical function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Hip abductor strength

Key secondary outcomes

knee extensor strength
muscle mass of upper and lower limb
Grip strength
Cross-sectional aera of the brachium
Functional Indepndence Measure
10-m timed gait test


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Branched amino acid supplement
3.4g(6.8g)/ 1 month

Interventions/Control_2

starch 1.2g/ 1 month

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

70 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Patients with no deglutition disorder.

Key exclusion criteria

1) Persons with past surgical history
2) Persons with renal disorder who need
to protein restriction
3) Persons with progressive disorder of
the nervous system and muscle
4) Patients scheduled for conventional
total hip arthroplasty.
5) Patients scheduled for arthroplasy
with osteotomy
6) Patients scheduled for arthroplasy
with hip adductor muscle dehiscence
7) Patients with dementia
8) Patients with the depression or
schizophrenic disorder
9) Patients with cerebro-vascular
disease
10) Patients with untreated cardio
-vascular disorder

Target sample size

55


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Ikeda

Organization

Showa University

Division name

School of Nrsing and Rehabilitation sciences

Zip code

227-8517

Address

2-1-1, Fujigaoka Aoba YOKOHAMA, KANAGAWA

TEL

+81-045-974-2221

Email

tk.ikeda@nr.showa-u.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Ikeda

Organization

Showa University

Division name

School of Nrsing and Rehabilitation sciences

Zip code

227-8517

Address

2-1-1, Fujigaoka Aoba YOKOHAMA, KANAGAWA

TEL

+81-045-974-2221

Homepage URL


Email

tk.ikeda@nr.showa-u.ac.jp


Sponsor or person

Institute

Showa University Fujigaoka Hospital

Institute

Department

Personal name



Funding Source

Organization

Showa University, School of Nrsing and Rehabilitation sciences

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Showa University Fujigaoka hospital ethic commttiee

Address

2-1-1 Fujigaoka, Aoba ward

Tel

045-974-6329

Email

f-irb@cmed.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学藤が丘リハビリテーション病院: Showa University Fujigaoka Rehabilitation Hospital


Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 15 Day


Related information

URL releasing protocol

none

Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/31826368

Number of participants that the trial has enrolled

31

Results

BCAA supplementation combined with muscle strengthening exercises had a significant effect on knee extension strength of the contralateral side and on upper arm cross-sectional area. The improvement ratio of knee extension strength before and after intervention on the operated side was also significantly higher in the BCAA group.

Results date posted

2020 Year 07 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2019 Year 12 Month 01 Day

Baseline Characteristics

The eligible patients were 31 elderly women who were admitted to a ward for rehabilitation during convalescence after THA and revisions.

Participant flow

A one-month period of supplementation was
combined with physical exercises.

Adverse events

none

Outcome measures

Demographic data were collected from clinical records and included age, body mass index (BMI), co-morbidity index, diagnosis, surgical procedure, duration of hospital stay, the number of combined therapy sessions, nutritional status, and prescribed analgesic medicines. The antiinflammatory activity of non-steroidal anti-inflammatory drugs (NSAIDs) has been reported to impair satellite cell activity, which is required for muscle protein synthesis. Evaluations were conducted in the preintervention period and the post-intervention period. Investigators assessed muscle strength, skeletal muscle mass, and the functional independence measure (FIM)
score.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 01 Month 24 Day

Date of IRB

2017 Year 02 Month 15 Day

Anticipated trial start date

2017 Year 02 Month 28 Day

Last follow-up date

2018 Year 03 Month 25 Day

Date of closure to data entry

2018 Year 03 Month 25 Day

Date trial data considered complete

2018 Year 03 Month 31 Day

Date analysis concluded

2018 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 02 Month 15 Day

Last modified on

2020 Year 07 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030047


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name